These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11215099)

  • 1. [Quality assurance of the molecular diagnostic tests in hematological malignancies].
    Miyachi H
    Rinsho Byori; 2000 Oct; 48(10):892-9. PubMed ID: 11215099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic efficacy for measurement of real-time quantitative PCR-based major bcr/abl mRNA in patients with Philadelphia chromosome-positive leukemia].
    Takahata M; Hashino S; Fujisawa F; Kondo T; Ota S; Kobayashi S; Tanaka J; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Dec; 45(12):1241-6. PubMed ID: 15678915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia.
    Zanella I; Rossi G; Finazzi D; Capucci A; Albertini A; Cariani E
    Haematologica; 2001 Mar; 86(3):318-9. PubMed ID: 11255281
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
    Amabile M; Giannini B; Testoni N; Montefusco V; Rosti G; Zardini C; Terragna C; Buonamici S; Ottaviani E; Soverini S; Fiacchini M; Bassi S; de Vivo A; Trabacchi E; Saglio G; Pane F; Baccarani M; Tura S; Martinelli G
    Haematologica; 2001 Mar; 86(3):252-9. PubMed ID: 11255271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].
    Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K
    Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expanding scope and impact of services provided by clinical laboratory practice through molecular diagnostics].
    Miyachi H
    Rinsho Byori; 1999 Oct; 47(10):919-25. PubMed ID: 10590665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.
    Thörn I; Olsson-Strömberg U; Ohlsen C; Jonsson AM; Klangby U; Simonsson B; Barbany G
    Haematologica; 2005 Nov; 90(11):1471-6. PubMed ID: 16266893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RT-PCR use for the diagnostic of chronic myeloid leukaemia].
    Menif S; El Borgi W; Jeddi R; Belakhal R; Elloumi M; Laatiri A; Meddeb B; Dellagi K
    Arch Inst Pasteur Tunis; 2006; 83(1-4):35-9. PubMed ID: 19388595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular detection of the BCR-ABL gen by RT-PCR in Costa Rican children with leukemia].
    Jiménez-Arce G; Carrillo J; Chaves M; Jiménez R; Vargas M; Campos L; de la Guardia A; Valverde B
    Rev Biol Trop; 2008 Dec; 56(4):1613-8. PubMed ID: 19419069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
    Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
    Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular relapse of chronic myeloid leukemia after discontinuation of imatinib mesylate for maintaining complete molecular response for more than 2 years].
    Kiguchi T; Tauchi T; Ohyashiki K
    Rinsho Ketsueki; 2009 Jan; 50(1):52-4. PubMed ID: 19225231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia.
    Campanini F; Santucci MA; Pattachini L; Brusa G; Piccioli M; Barbieri E; Babini L; Tura S
    Haematologica; 2001 Feb; 86(2):167-73. PubMed ID: 11224486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
    Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
    Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
    Beránek M; Voglová J; Sýkorová A; Belada D; Bláha M
    Cas Lek Cesk; 2006; 145(1):25-9; discussion 29-30. PubMed ID: 16468238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile].
    Artigas CG; Melo A; Roa JC; Páez E; Vittini C; Arriagada M; González L; Pflaumer E; Roa I
    Rev Med Chil; 2002 Jun; 130(6):623-30. PubMed ID: 12194684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive validation of a real-time quantitative bcr-abl assay for clinical laboratory use.
    Jones CD; Yeung C; Zehnder JL
    Am J Clin Pathol; 2003 Jul; 120(1):42-8. PubMed ID: 12866371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.